Step 1 topics → General Pathology → Tumor Suppressors (Knudson Two-Hit)

Tumor Suppressors (Knudson Two-Hit)

USMLE Step 1 trap: Confuses the two-hit requirement in hereditary (1 germline + 1 somatic) vs. sporadic (2 somatic) cancers. In hereditary syndromes, one germline mutation is inherited and only one additional somatic hit is needed, lowering the threshold for tumor development.

Tumor suppressors are the brakes of the cell cycle, and USMLE Step 1 tests them from molecular mechanism all the way to clinical genetics. They are proteins that normally restrain proliferation, trigger DNA repair, or initiate apoptosis when things go wrong — and the Knudson two-hit hypothesis explains why losing these genes leads to cancer: both copies must be inactivated before the brake is fully released. Step 1 loves this topic because it connects mechanism to specific syndromes like Li-Fraumeni, FAP, and hereditary breast/ovarian cancer.

The exam tests this at multiple levels. Pure recall questions ask which gene is lost in which syndrome (RB1 → retinoblastoma, APC → FAP, BRCA1/2 → breast/ovarian). Mechanism questions ask how p53 actually responds to DNA damage, or what happens to E2F when Rb gets phosphorylated. Passage-based questions might give you a family pedigree with early-onset bilateral tumors and ask you to explain the genetic basis — that's where the sporadic vs. hereditary distinction becomes critical.

What makes this topic consistently tricky is that students memorize gene names without understanding the underlying logic, then fall apart on mechanism questions. The Rb phosphorylation direction is one of the most reliably tested sources of confusion on USMLE Step 1 — students remember 'Rb blocks the cell cycle' but get the phosphorylation state backwards. Similarly, p53 is almost always described as 'causing apoptosis,' which is incomplete and will cost you on a nuanced vignette. Get the mechanisms right and the syndrome associations become much easier to anchor.

From real student decks
59%have cards covering this topic
30%have mature cards

Common misconceptions

Common mistake
Wrong: Hereditary cancer syndromes require two somatic mutations just like sporadic cancers.
Right: In hereditary syndromes, one germline mutation is inherited and only one additional somatic hit is needed, lowering the threshold for tumor development.
In sporadic cancers, a cell must acquire two independent somatic mutations in the same tumor suppressor gene — a statistically rare event that explains why sporadic tumors appear later in life. In hereditary syndromes, every cell in the body already carries one defective germline copy, so only one additional somatic hit is needed to knock out the remaining functional allele. This is why hereditary cancers present earlier, are more likely to be bilateral, and often affect multiple family members — the bar for losing both copies is cut in half from conception.
Common mistake
Wrong: P53 always triggers apoptosis after DNA damage regardless of damage severity.
Right: p53 first induces p21-mediated G1 arrest for repair; apoptosis via BAX/PUMA upregulation occurs only when damage is irreparable.
p53 doesn't go straight to apoptosis — it first tries to save the cell. After DNA damage, p53 transcribes p21, a CDK inhibitor that stalls cyclin E/CDK2 and halts progression at the G1-S checkpoint, buying time for repair machinery. Apoptosis via BAX and PUMA upregulation is the fallback when damage is too extensive to fix. Treating p53 as a pure 'death switch' will get you burned on questions that ask about its initial protective response or why p53 loss leads to both unchecked proliferation and apoptosis resistance.
Common mistake
Wrong: Phosphorylated (active) Rb blocks E2F and prevents cell cycle progression.
Right: Hypophosphorylated Rb sequesters E2F and blocks S-phase entry; cyclin D/CDK4 phosphorylation of Rb releases E2F to allow progression.
Lock in this rule: hypophosphorylated Rb is the active brake. In G1, unphosphorylated Rb grips E2F and keeps it inactive, preventing S-phase entry. Cyclin D (induced by mitogenic signals) activates CDK4/6, which phosphorylates Rb, causing a conformational change that releases E2F — now free to transcribe genes needed for DNA replication. So phosphorylated Rb = released brake = cell cycle ON. When CDK inhibitors like p16 or p21 are lost or Rb itself is mutated, this checkpoint collapses.
Common mistake
Wrong: BRCA1/2 mutations cause retinoblastoma.
Right: RB1 mutations cause retinoblastoma; BRCA1/2 mutations predispose to hereditary breast and ovarian cancer.
RB1 and BRCA1/2 are completely different genes on different chromosomes causing completely different syndromes — the only overlap is that both follow the two-hit model. RB1 encodes the retinoblastoma protein that controls the G1-S checkpoint; loss causes retinoblastoma (childhood eye tumor) and osteosarcoma. BRCA1/2 encode DNA repair proteins involved in homologous recombination; loss predisposes to breast, ovarian, and prostate cancers. The naming similarity (both start with 'B') trips up students who haven't explicitly paired each gene with its syndrome.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Understand the Knudson two-hit model mechanistically: why two independent loss-of-function events are required to inactivate a tumor suppressor, and how this differs between sporadic (two somatic hits) and hereditary (one germline + one somatic hit) cancers.
  2. Know the high-yield tumor suppressors paired with their associated syndromes and tumor types: RB1/retinoblastoma, TP53/Li-Fraumeni, APC/FAP, BRCA1-2/hereditary breast-ovarian cancer, VHL/clear cell renal carcinoma, NF1/neurofibromatosis type 1, NF2/neurofibromatosis type 2, WT1/Wilms tumor, PTEN/Cowden syndrome.
  3. Explain the p53 damage-response pathway in sequence: DNA damage → p53 stabilization → p21 upregulation → CDK inhibition → G1 arrest → repair attempt; if damage is irreparable, p53 upregulates BAX and PUMA to trigger apoptosis.
  4. Trace the Rb/E2F pathway at the G1-S checkpoint: hypophosphorylated Rb binds and sequesters E2F; cyclin D/CDK4-6 phosphorylates Rb; phosphorylated Rb releases E2F; E2F drives S-phase gene transcription.

Can you avoid these mistakes?

A 4-year-old presents with bilateral retinoblastoma. His father had unilateral retinoblastoma as a child. Explain why this child developed bilateral disease at a younger age than the sporadic form, using the two-hit model.
After UV-induced DNA damage, a keratinocyte activates p53. Walk through the sequence of molecular events that follows — what happens first, and under what condition does the cell commit to apoptosis instead of repair?
A researcher knocks out cyclin D in a cell line. Predict what happens to Rb phosphorylation status and E2F activity, and explain what this means for cell cycle progression.
A patient is found to carry a germline BRCA2 mutation. Her oncologist explains this increases cancer risk. A medical student incorrectly documents this as 'RB1 mutation causing retinoblastoma risk.' What are the two errors in this documentation, and what is the correct gene-syndrome pairing for each?

Related topics

Hallmarks of Cancer Oncogenes Reversible vs Irreversible Cell Injury Types of Necrosis Apoptosis (Intrinsic and Extrinsic Pathways) Cell Adaptations (Atrophy, Hypertrophy, Hyperplasia, Metaplasia, Dysplasia)

See how your Anki deck covers this topic.

Upload your deck for a free audit →